Psychiatric Consultation Through Videoconference in a Primary Care Setting

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by Sha’ar Menashe Mental Health Center.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Galil Center for Telemedicine and Medical Informatics
Information provided by:
Sha’ar Menashe Mental Health Center
ClinicalTrials.gov Identifier:
NCT00298961
First received: March 2, 2006
Last updated: May 20, 2008
Last verified: May 2008
  Purpose

In our study we will aim to examine the issues of cost analysis, quality of life, clinical efficacy and satisfaction of psychiatric consultations through videoconference in a primary care setting in comparison with in-person psychiatric treatment and primary care only. The main hypotheses of the study are: Satisfaction of the patients will increase, the use of telepsychiatry will reduce the costs for the primary and mental health care centers as well as for the patients, the treatment will be as effective as in-person treatment, the number of patients referred to mental health treatment will be higher than that of the previous year, quality of life will improve and that there will be a stigma reduction of mental illness.


Condition Intervention
Remote Consultation
Community Psychiatry
Device: Videoconference equipment FALCON/IP

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Telepsychiatry: Cost Analysis, Quality of Life, Satisfaction and Effectiveness of Psychiatric Consultation Through Videoconference in a Primary Care Setting

Resource links provided by NLM:


Further study details as provided by Sha’ar Menashe Mental Health Center:

Primary Outcome Measures:
  • Brief Psychiatric Rating Scale (BPRS) at 0 months, 6 months and 12 months.

Secondary Outcome Measures:
  • Clinical Global Impression Scale (CGI) at 0 months, 6 months and 12 months.
  • Hamilton Anxiety Rating Scale (HAM-A) at 0 months, 6 months and 12 months.
  • Hamilton Depression Rating Scale (HAM-D) at 0 months, 6 months and 12 months.
  • Global satisfaction questionnaire at 0 months, 6 months and 12 months.
  • General Health Questionnaire 11 (GHQ11) at 0 months, 6 months and 12 months.
  • Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-18) at 0 months, 6 months and 12 months.
  • Costs: Travel expenses, extra consultations, hospitalizations, Medication, loss of work days, medical visitations, ancillary tests such as ECG, lab tests and others at 0 months, 6 months and 12 months.

Estimated Enrollment: 160
Study Start Date: May 2006
Estimated Study Completion Date: November 2007
  Hide Detailed Description

Detailed Description:

Telepsychiatry, as a method which utilizes videoconferencing as a means for consultation, examination and treatment of patients as a substitute for in-person treatment has been in use now for over 40 years. With telepsychiatry there is an attempt to deal with the issues of providing service to patients who reside at a considerable distance from the mental health facilities or that conversely do not call for mental health services for other diverse reasons such as loss of work days, social stigma, travel expenses and so forth.

In Israel, mental health services are provided to 1.5% of the population whereas the incidence in other developed countries is significantly higher, reaching 3-5%, while the prevalence of mental illness in Israel is similar. One can hypothesize that the above factors such as social stigma, mental health care availability, loss of work days and travel expenses all play a role in this. Consequently, patients may prefer to see their primary care physician as an alternative, and according to reports of the Israeli national health services, 30%-50% of visits to the primary care physician are mental health related. Thanks to the technological advances in telecommunications, especially regarding cost reduction and higher bandwidths, there has been a renewed interest in telepsychiatry. However, the issue of the cost effectiveness of telepsychiatry is still controversial. Out of 380 studies on telepsychiatry published from 1956 to 2002, only 12 dealt with the question of cost effectiveness, and among those the results were equivocal. Another question that has scarcely been studied is that of quality of life within telepsychiatry treatment. Finally, the issue of telepsychiatry that is used as a consultation tool in the aid of the primary physician that occurs physically in his own practice is another novel angle we wish to explore. The advantages embodied in this are potentially many - patient discreteness and confidentiality, decrease in expenses and stigma reduction among others.

In our study we will attempt to address the above issues that have not received the focus of attention in many of the published studies so far - cost analysis and quality of life within the context of telepsychiatry consultation in primary care. Additionally, we will address the issues of clinical efficacy and satisfaction (of the primary care provider as well as that of the patient) from the treatment.

Our study hypotheses are:

  1. The satisfaction of the patients will increase during the 12 months of study in the group treated by telepsychiatry in comparison with the control groups.
  2. Cost analysis - the use of telepsychiatry will reduce the costs for the primary health care centers and/or for the mental health centers: Travel expenses, a decrease in visitations to the primary health care center, a decrease in hospitalizations in general hospitals and/or psychiatric hospitals, a decrease in the number of ancillary tests and of lost work days.
  3. Effectiveness of treatment - the mental and physical well being of the patients will improve or at least not be impaired in the group treated by telepsychiatry as compared to the control groups due to the increased availability of the consultation service.
  4. The number of patients referred to mental health treatment will be higher than that of the previous year due to the increased availability of telepsychiatry within the primary care setting.
  5. The patients will prefer the telepsychiatry service as compared to a referral to a mental health center.
  6. Quality of life will improve or it least not be impaired in the group treated by telepsychiatry as compared to the control groups.
  7. Stigma reduction - Visitations to the primary health care center as opposed to the mental health center will lower the possibility of the formation of a social stigma of mental disease.

Comparison Groups:

  1. Telepsychiatry treated patients within the primary care setting.
  2. In-person treated patients by a psychiatrist at the mental health center.
  3. Primary care treated patients without a psychiatry consultation.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients referred by the primary care physician.
  • Age 18 and over.
  • Speak Hebrew.

Exclusion Criteria:

  • Patients that suffer from severe dementia.
  • Patients suffering from addiction to drugs or alcohol.
  • Patients who are deaf, dumb or blind.
  • Patients who have a legal guardian.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00298961

Contacts
Contact: Mahmud Jabarin, MD +972-4-6278110 jabarin@shaar-menashe.org.il
Contact: Ehud Susser, MD +972-4-6278946 udiwudi@yahoo.com

Locations
Israel
Sha'ar Menashe Mental Health Center Ambulatory Clinic Recruiting
Hadera, Israel, 38814
Contact: Mahmud Jabarin, MD    +972-4-6278110    jabarin@shaar-menashe.org.il   
Contact: Ehud Susser, MD    +972-4-6278946    udiwudi@yahoo.com   
Principal Investigator: Mahmud Jabarin, MD         
Sponsors and Collaborators
Sha’ar Menashe Mental Health Center
Galil Center for Telemedicine and Medical Informatics
Investigators
Principal Investigator: Mahmud Jabarin, MD Sha'ar Menashe Mental Health Center, Israel
Study Chair: Ilan Modai, MD, MHA Sha'ar Menashe Mental Health Center, Israel
Study Chair: Ehud Susser, MD Sha'ar Menashe Mental Health Center, Israel
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00298961     History of Changes
Other Study ID Numbers: TelepsychiatryCTIL
Study First Received: March 2, 2006
Last Updated: May 20, 2008
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

ClinicalTrials.gov processed this record on October 20, 2014